chapter 49 Men as patients Flashcards
hypogonadism
- failure of testes to produce androgens or sperm or both
- main cause of male infertility
- primary: low testosterone and elevated gonadotropins
- secondary: low testosterone and low/normal gonadotropins
- tertiary: older men with high gonadotropins and normal testosterone
- in infancy: persistent failure of testes to descend may be pre-cursor to testicular dysfunction,or hypotrophic penis
- in puberty: delayed, absent or arrested testicular growth, voice doesn’t deepen, and little muscle mass in gained
- in adulthood: reproductive function stops, emotionally similar to menopause
uses of testosterone replacement therapy
- for anemia: endogenous androgens stimulate erythropoiesis, increase hgb levels
- for bone density: testosterone plays major role in bone density
- for cognitive function: higher free testosterone concentrations associated with better performance of memory and cognitive function
- for lower urinary tract symptoms: increases bladder capacity and compliance
- for metabolic syndrome and DM 2: modulates insulin resistance and risk for metabolic syndrome
- for mood, energy, quality of life
- for muscle mass and strength
- for libido, sexual function, performance
risks/contraindications for testosterone therapy
- erythrocytosis risk-monitor h/h->17.5 g/dL hgb or >54% hct overdose/abuse
- hypoxia, sleep apnea
- prostate ca
- boys-acne and gynecomastia, aggressive behavior, premature epiphyses-leading to short stature
- adolescents - “rhoid rage”
drug interaction with testosterone therapy
- high risk medication: anisindione, dicumarol, warfarin
- if necessary-dosage may need to be adjusted
common problems that require medication for males
- erectile dysfunction:trt, phodiesterase type 5 inhibitors
- benign prostatic hyperplasia
- prostatitis/male pelvic pain syndrome
- hair loss
leading causes of death in men
-heart disease, cancer, unintentional accidents
average normal testosterone level in men
normal:400-600 ng/dL
testosterone clinical use and dosing
- depot esters 200 mg IM every 2 wks
- transdermal or buccal resulting in systemic absorption of 2.5 mg-10 mg daily
monitoring while on TRT
- evaluate efficacy 3-6 months with checks of testosterone levels (goal 400-600) and h/h
- eval bone density every 1-2 years
- eval PSA levels and digital rectal exam before therapy and 3&6 months
erectile dysfunction
tx; TRT, phosphodietrase type 5 (PDE-5) inhibitors-taken 1-4 hours prior to sexual activity
i. e. sildenafil (viagra), vardenafil (Levitra), tadalafil (cialis)
- side effects: hearing and vision problems
hair loss
tx: topical minoxidil, systemic finasteride
monitoring: can take up to 1 year to see improvement
- liver toxic and increase in PSA
- toxic to fetus
homosexual men
- higher rates of HIV and syphilis
- 17x greater incidences of anal cancer than heterosexual men
- 33% of gay men smoke